Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.

Abstract:

:Elevated levels of p21WAF1/CIP1, an important mediator of DNA repair, have been observed in various aggressive tumors as well as linked to chemoresistance. We examined whether heregulin (HRG), a member of the EGF-like growth factor family closely related to breast cancer tumorigenesis and metastasis, modulates p21WAF1/CIP1 expression and cellular localization. We used a model system that consisted of MCF-7 cells and MCF-7 cells engineered to overexpress the full-length cDNA of the human HRG gene (MCF-7/HRG). MCF-7/HRG cells demonstrate constitutive hyperactivation of Her-2/neu receptor as well as activation of down-stream PI-3'K/AKT and MAPK signaling cascades. Immunoblotting analyses showed that MCF-7/HRG cells significantly up-regulate p21WAF1/CIP1 expression relative to control MCF-7/pBABE cells, while a strong nuclear accumulation of p21WAF1/CIP1 in MCF-7/HRG cells was revealed by immunofluorescence microscopy studies. Protein degradation analyses demonstrated that the half-life of p21WAF1/CIP1 protein was increased from approximately 35 min in control MCF-7/pBABE cells to >/=3 h in MCF-7/HRG cells. Pharmacological inactivation of the PI-3'K/AKT and MAPK completely prevented HRG-induced accumulation of p21WAF1/CIP1. A structural deletion mutant of HRG (HRG-M4) lacking the N-terminus sequence and the cytoplasmic-transmembrane region of HRG was generated to investigate whether secretion of HRG and transactivation of Her-2/neu actively contributed to HRG-regulated p21WAF1/CIP1 expression and cellular localization. MCF-7 cells engineered to overexpress HRG-M4 did not demonstrate either activation of Her-2/neu, PI-3'K/AKT, or MAPK. Remarkably, HRG-M4 overexpression completely abolished the ability of HRG to promote nuclear accumulation of p21WAF1/CIP1 and concomitantly enhanced the apoptotic effects of cisplatin towards breast cancer cells. This novel interplay between HRG and p21WAF1/CIP1 strongly suggests that one mechanism of HRG-regulated breast cancer cell proliferation, survival, and/or sensitivity to genotoxic damage is to stabilize and promote a nuclear accumulation of p21WAF1/CIP1.

journal_name

Int J Oncol

authors

Menendez JA,Mehmi I,Lupu R

keywords:

subject

Has Abstract

pub_date

2005-03-01 00:00:00

pages

649-59

issue

3

eissn

1019-6439

issn

1791-2423

journal_volume

26

pub_type

杂志文章
  • HLA class I antigens are possible prognostic factors in hepatocellular carcinoma.

    abstract::Thirty patients who underwent hepatectomy for the treatment of hepatocellular carcinoma (HCC) were examined for expression of HLA class I antigens on HCC cells by flow cytometry. The expression was found significantly lower in cases of stage IV compared with those of stage I or stage II (p<0.05), and in cases of intra...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.8.6.1243

    authors: Nishibe M,Une Y,Kobayashi M,Kuramitsu Y,Hosokawa M,Uchino J

    更新日期:1996-06-01 00:00:00

  • Screening of peptides which suppress the proliferation of transformed cells.

    abstract::We have carried out three rounds of screening tests using 239 synthetic tripeptides for the growth-inhibitory activity toward tumor cells and found that those having amino acid sequences of Pro-Thr-Trp or Glu-Arg-Pro effectively inhibit proliferation of transformed cells. These peptides could be the fundamental struct...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Hiwasa T,Soeda C,Takanohashi S,Kobayashi H,Suzuki A,Ueyama T,Ike Y

    更新日期:1996-01-01 00:00:00

  • Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.

    abstract::Gastrointestinal stromal tumors (GISTs), are characterized by mutations of the KIT or platelet-derived growth factor receptor-α gene and the constitutive expression of Kit, which is currently being studied as a potential therapeutic target. In this study, we addressed the question of whether the microRNA (miRNA) 221/2...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2010.857

    authors: Koelz M,Lense J,Wrba F,Scheffler M,Dienes HP,Odenthal M

    更新日期:2011-02-01 00:00:00

  • Treatment of hepatocellular carcinoma and the exacerbation of liver function.

    abstract::We performed interventional treatments on 50 patients with hepatocellular carcinoma (HCC) and analyzed the relationship between these treatments and the exacerbation of liver function after treatment. The different treatments included transcatheter arterial embolization (TAE), percutaneous ethanol injection therapy (P...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.19.6.1279

    authors: Okano H,Shiraki K,Inoue H,Deguchi M,Sugimoto K,Sakai T,Ohmori S,Murata K,Nakano T,Yamakado K,Takeda K

    更新日期:2001-12-01 00:00:00

  • Trophic and neurotrophic factors in human pituitary adenomas (Review).

    abstract::The pituitary gland is an organ that functionally connects the hypothalamus with the peripheral organs. The pituitary gland is an important regulator of body homeostasis during development, stress, and other processes. Pituitary adenomas are a group of tumors arising from the pituitary gland: they may be subdivided in...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.2017.4120

    authors: Spoletini M,Taurone S,Tombolini M,Minni A,Altissimi G,Wierzbicki V,Giangaspero F,Parnigotto PP,Artico M,Bardella L,Agostinelli E,Pastore FS

    更新日期:2017-10-01 00:00:00

  • Dihydropyrimidine dehydrogenase, multidrug resistance-associated protein, and thymidylate synthase gene expression levels can predict 5-fluorouracil resistance in human gastrointestinal cancer cells.

    abstract::Gene expression of dihydropyrimidine dehydrogenase (DPD) and newly multidrug resistance-associated protein (MRP) was found to correlate well with primary 5-FU resistance in 7 human gastrointestinal cancer cell lines. Although mRNA and protein levels of thymidylate synthase (TS) did not relate to the resistance, 5-FU t...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.14.3.551

    authors: Kirihara Y,Yamamoto W,Toge T,Nishiyama M

    更新日期:1999-03-01 00:00:00

  • Expression of activin and activin receptors in human prostatic-carcinoma cell-line du145.

    abstract::The purpose of this study was to determine whether DU145, a human prostate cancer cell line: (a) transcribes mRNAs coding for beta A- and beta B-subunits of activin, a member of transforming growth factor beta (TGF beta) superfamily, and activin receptors I, II, and IIB; and (b) produces activin proteins. The expressi...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.7.2.239

    authors: Furst B,Zhang Z,Ying S

    更新日期:1995-08-01 00:00:00

  • Isoform switch of CD44 induces different chemotactic and tumorigenic ability in gallbladder cancer.

    abstract::Gallbladder cancer (GBC) is one of the most unfavorable prognostic tumor, and immediate growth and distant metastasis are important factors associated with the poor prognosis of patients with this disease. Standard and variant isoforms of CD44 are associated with tumor growth, metastasis, and epithelial-mesenchymal tr...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2017.4063

    authors: Miwa T,Nagata T,Kojima H,Sekine S,Okumura T

    更新日期:2017-09-01 00:00:00

  • Hormone-dependent human tumors express the fms gene-product.

    abstract::Human mammary and thyroid tumors as well as peripheral blood cells of the same patients were examined for the amplification of oncogene fins and the expression of its product. Of the 7 mammary tumors analyzed, amplification of fms was observed in 6 (86%) mammary tumor DNAs, while no amplification was seen in 5 thyroid...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.5.4.769

    authors: Haga S,Imai S,Morimoto J,Okumoto M,Nishikawa R,Mori N,Kiyozuka Y,Nagano K,Nishino T,Yamamoto H,Sarkar N

    更新日期:1994-10-01 00:00:00

  • miRNA expression pattern associated with prognosis in elderly patients with advanced OPSC and OCC.

    abstract::The long-term survival for elderly patients with advanced ovarian papillary serous carcinoma (OPSC) does not exceed 30%, and the incidence and prognosis rise continuously after menopause. The aim of this study was to identify the differences in key miRNAs and their potential regulators through miRNA microarray analysi...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2013.1988

    authors: Zhao H,Ding Y,Tie B,Sun ZF,Jiang JY,Zhao J,Lin X,Cui S

    更新日期:2013-09-01 00:00:00

  • A critical perspective in cancer research (Review).

    abstract::Over the past few decades, there has been a tremendous increase in cancer biology data and treatment. Cancer research has opened exciting new areas of cellular and molecular biology. Month by month, new genes which regulate the carcinogenesis process are being discovered. The result is an incredible knowledge of cance...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.15.6.1213

    authors: Kanduc D,Bannasch P,Farber E

    更新日期:1999-12-01 00:00:00

  • Human tumor-cell growth modulatory effects of the aebs/hic-binding drugs used as single agents and in combination with a novel amphibian oocyte rnase.

    abstract::A novel amphibian oocyte RNase, ONCONASE(R) (ONC), has been previously shown to have synergistic tumor cell growth inhibitory activity when combined with tamoxifen (TMX) and/or trifluoperazine (TFP) in human ASPC-1 pancreatic and A-549 lung carcinoma cells, respectively. It has recently been reported that several drug...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2.5.807

    authors: Mikulski S,Viera A,Shogen K

    更新日期:1993-05-01 00:00:00

  • Gamma linolenic acid inhibits tyrosine phosphorylation of focal adhesion kinase and paxillin and tumour cell matrix interaction.

    abstract::Gamma linolenic acid (GLA) is an anti-cancer agent recently reported to inhibit tumour cell-matrix attachment. This study examined the effects of GLA on the adhesion of two tumour cell lines, HT115 (human colon) and MDA MB 231 (human breast), to an extracellular matrix, Matrigel. The action of GLA on focal adhesion ki...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.8.3.583

    authors: Jiang W,Hiscox S,Puntis M,Hallett M,Bryce R,Horrobin D,Mansel R

    更新日期:1996-03-01 00:00:00

  • The levels of HDAC1 and thioredoxin1 are related to the death of mesothelioma cells by suberoylanilide hydroxamic acid.

    abstract::Mesothelioma is an aggressive tumor which is mainly derived from the pleura of lung. In the present study, we evaluated the anticancer effect of suberoylanilide hydroxamic acid (SAHA), a histone deacetylase (HDAC) inhibitor on human mesothelioma cells in relation to the levels of HDAC1, reactive oxygen species (ROS) a...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2016.3402

    authors: You BR,Park WH

    更新日期:2016-05-01 00:00:00

  • Genetic identification and management of hereditary nonpolyposis colorectal cancer.

    abstract::Hereditary nonpolyposis colorectal cancer (HNPCC) is a syndrome involving a predisposition to cancers of the colon, endometrium and several other extra-colonic sites, accounting for approximately 1-5% of all colorectal cancer cases. It is not easily recognized because of a lack of distinctive clinical markers, making ...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.12.4.947

    authors: Park JG,Yuan Y

    更新日期:1998-04-01 00:00:00

  • Expression of Müllerian inhibiting substance type II receptor and antiproliferative effects of MIS on human cervical cancer.

    abstract::This study aimed to analyze expression of Müllerian inhibiting substance type II receptor (MISRII) protein and mRNA in cervical neoplasia, to demonstrate the growth inhibition of cervical cancer cells by administration of highly purified recombinant human Müllerian inhibiting substa...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1370

    authors: Song JY,Jo HH,Kim MR,Lew YO,Ryu KS,Cha JH,Kang CS,Donahoe PK,MacLaughlin DT,Kim JH

    更新日期:2012-06-01 00:00:00

  • Combinatory anti-tumor effects of electroporation-mediated chemotherapy and wild-type p53 gene transfer to human esophageal cancer cells.

    abstract::Delivery of electric pulses to an established solid tumor augments the permeability of cell membrane and increases the susceptibility of tumors to an anti-cancer agent that is administered in the vicinity of tumors. Forced expression of the wild-type p53 gene in tumor cells that have non-functional p53 gene(s) can als...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.18.4.825

    authors: Matsubara H,Maeda T,Gunji Y,Koide Y,Asano T,Ochiai T,Sakiyama S,Tagawa M

    更新日期:2001-04-01 00:00:00

  • CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.

    abstract::From January 1992 to December 1995, 129 patients with previously untreated non-Hodgkin's lymphoma were randomised in a phase III multicenter trial to receive CEOP-B/VIMB or ProMACE-CytaBOM. Eligibility criteria included intermediate or high grade lymphoma (follicular large cell, diffuse small cleaved-cell, diffuse mix...

    journal_title:International journal of oncology

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.3892/ijo.16.1.149

    authors: Lorusso V,Palmieri G,Bianco AR,Abate G,Catalano G,De Vita F,Dammacco F,Lauta VM,Lucarelli G,Polimeno G,Mantovani G,D'Aprile M,Marzullo F,De Lena M

    更新日期:2000-01-01 00:00:00

  • Regulatory T cells actively infiltrate metastatic brain tumors.

    abstract::Regulatory T cells (CD4+CD25+FoxP3+, Treg) have been shown to play a major role in suppression of the immune response to malignant gliomas. In this study, we investigated the kinetics of Treg infiltration in metastatic brain tumor models, including melanoma, breast and colon cancers. Our data indicate that both CD4+ a...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo_00000282

    authors: Sugihara AQ,Rolle CE,Lesniak MS

    更新日期:2009-06-01 00:00:00

  • Cytokine regulation of constitutive production of interleukin-8 and -6 by human pancreatic cancer cell lines and serum cytokine concentrations in patients with pancreatic cancer.

    abstract::Patients with pancreatic cancer frequently demonstrate symptoms such as weight-loss and muscle wasting and have clinical evidence of a systemic inflammatory response. Such effects may be mediated by pro-inflammatory cytokines derived from tumor cells. The production of interleukin-6 and -8 by pancreatic cancer cell li...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.21.4.881

    authors: Wigmore SJ,Fearon KC,Sangster K,Maingay JP,Garden OJ,Ross JA

    更新日期:2002-10-01 00:00:00

  • Expression of CD44 spliced variants with both exons v9 and v10 in primary N(-)M(-) breast carcinomas correlates with metastasis.

    abstract::We analyzed the representation of CD44 isoforms with both exons v9 and v10 among CD44 total amount and also examined correlation between their expression, clinical parameters and survival. We used a semi-quantitative RT-PCR reaction and a panel of 25 normal breast specimens, 10 mammary fibroadenomas, 8 cystic samples ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.10.1.171

    authors: Guriec N,Gairard B,Marcellin L,Wilk A,Calderoli H,Renaud R,Bergerat J,Oberling F

    更新日期:1997-01-01 00:00:00

  • Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma.

    abstract::Photodynamic therapy (PDT) following lung-sparing extended pleurectomy for malignant pleural mesothelioma (MPM) has been investigated as a potential means to kill residual microscopic cells. High expression levels of folate receptor 1 (FOLR1) have been reported in MPM; therefore, targeting FOLR1 has been considered a ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2018.4555

    authors: Kato T,Jin CS,Lee D,Ujiie H,Fujino K,Hu HP,Wada H,Wu L,Chen J,Weersink RA,Kanno H,Hatanaka Y,Hatanaka KC,Kaga K,Matsui Y,Matsuno Y,De Perrot M,Wilson BC,Zheng G,Yasufuku K

    更新日期:2018-11-01 00:00:00

  • Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.

    abstract::A putative tumor suppressor, PTEN/MMAC1 gene was recently identified at 10q23 and was found to be frequently altered in several types of human tumors. To determine the possible role of this gene in human ovarian tumors, we screened 31 unselected primary epithelial ovarian cancers with matched normal tissues and 7 ovar...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.13.1.101

    authors: Yokomizo A,Tindall DJ,Hartmann L,Jenkins RB,Smith DI,Liu W

    更新日期:1998-07-01 00:00:00

  • Adenovirus E1A orchestrates the urokinase-plasminogen activator system and upregulates PAI-2 expression, supporting a tumor suppressor effect.

    abstract::Invasiveness and metastatic potential are the two most important properties defining malignancy. The adeno-virus E1A (Ad-E1A) gene has a dual effect as a proliferative gene and as a tumor-suppressor gene, decreasing tumor growth and the metastatic potential of malignant cells. In order to study genes related with the ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Fernández-Soria V,Lleonart ME,Diaz-Fuertes M,Villuendas R,Sánchez-Prieto R,Fabra A,Ramón Y Cajal S

    更新日期:2006-01-01 00:00:00

  • Enhanced effect of photodynamic therapy in ovarian cancer using a nanoparticle drug delivery system.

    abstract::Nanoparticles are promising novel drug delivery carriers that allow tumor targeting and controlled drug release. In the present study, we prepared poly butyl-cyanoacrylate nanoparticles (PBCA-NP) entrapped with hypocrellin B (HB) to improve the effect of photodynamic therapy (PDT) in ovarian cancer. An ovarian cancer ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2015.3079

    authors: Li Z,Sun L,Lu Z,Su X,Yang Q,Qu X,Li L,Song K,Kong B

    更新日期:2015-09-01 00:00:00

  • Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.

    abstract::MicroRNAs (miRNAs) are a large family of small, non-coding RNAs that play a pivotal role in tumorigenesis. miR‑34a, which is a member of the miR-34 family, is a downstream target of p53. Increasing evidence shows that miR-34a dysregulation may contribute to tumor development and progression in numerous cancers, includ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2017.4015

    authors: Yang L,Song X,Zhu J,Li M,Ji Y,Wu F,Chen Y,Cui X,Hu J,Wang L,Cao Y,Wei Y,Zhang W,Li F

    更新日期:2017-07-01 00:00:00

  • Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.

    abstract::The negative signal provided by interactions of programmed death-1 (PD-1) and its ligands, B7-H1 and B7-DC, has been suggested to play an important role in tumor evasion from host immunity. Pancreas cancer patients with B7-H1 expression have a poor prognosis. B7-H1 blocking has been shown to inhibit the development of...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo_00000387

    authors: Okudaira K,Hokari R,Tsuzuki Y,Okada Y,Komoto S,Watanabe C,Kurihara C,Kawaguchi A,Nagao S,Azuma M,Yagita H,Miura S

    更新日期:2009-10-01 00:00:00

  • Regulatory role of nucleophosmin during the differentiation of human liver cancer cells.

    abstract::Nucleophosmin (NPM, also known as B23), mainly localized in the nucleolus, has been reported to be overexpressed in many types of human cancer, including colon, ovarian, prostate and gastric cancer. NPM was identified while screening the differential nuclear matrix proteins during HMBA-induced differentiation of human...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2407

    authors: Xu DH,Liu F,Li X,Chen XF,Jing GJ,Wu FY,Shi SL,Li QF

    更新日期:2014-07-01 00:00:00

  • Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

    abstract::MicroRNAs (miRNAs) are small non-coding, endogenous, single-stranded RNAs. MiRNAs have been implicated in different areas such as the immune response, neural development, DNA repair, apoptosis, oxidative stress response and cancer. However, while the majority of miRNAs are found int...

    journal_title:International journal of oncology

    pub_type: 杂志文章,评审

    doi:10.3892/ijo.2012.1647

    authors: Allegra A,Alonci A,Campo S,Penna G,Petrungaro A,Gerace D,Musolino C

    更新日期:2012-12-01 00:00:00

  • A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7, 12-dimethylbenz[a]anthracene-induced rat mammary tumors.

    abstract::Effects of vorozole, a potent and specific non-steroidal aromatase inhibitor, were evaluated on female Sprague-Dawley (SD) rats with 7, 12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors. Vorozole at a dose of 0.25, 1.0 and 4.0 mg/kg was orally administered once a day for 28 consecutive days. A significant reg...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Sugamata N,Koibuchi Y,Iino Y,Morishita Y

    更新日期:1999-02-01 00:00:00